Global phase III study of gemcitabine plus paclitaxel (GT) vs. paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC): First report of overall surviva-Reference-Cited by-同舟云学术

Global phase III study of gemcitabine plus paclitaxel (GT) vs. paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC): First report of overall surviva

Published:2004-07-15 Issue:14_suppl Volume:22 Page:510-510
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Albain K. S.¹,Nag S.¹,Calderillo-Ruiz G.¹,Jordaan J. P.¹,Llombart A.¹,Pluzanska A.¹,Pawlicki M.¹,Melemed A. S.¹,O'Shaughnessy J.¹,Reyes J. M.¹

Affiliation:

1. Loyola University Chicago Med Ctr, Maywood, IL; Inlaks and Budhrani Hospital, Pune, Maharashtra, India; Instituto Nacional De Cancerologia, Thalpan, Mexico; Addington Hospital, Durban, South Africa; Instituto Valenciano De Oncologia, Valencia, Spain; Klinika Chemioterapii, Lodz, Poland; Center of Oncology, Krakow, Poland; Baylor-Sammons Cancer Center, Dallas, TX; Clinicas Las Condes, Santiago, Chile

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.510

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-Drug Conjugates in Triple Negative Breast Cancer;Clinical Breast Cancer;2024-04

2. Toxic Effects of Gemcitabine and Paclitaxel Combination: Chemotherapy Drugs Exposure in Zebrafish;Toxics;2023-06-20

3. Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians;Cancers;2020-08-24

4. Chemotherapy and HER2-Directed Therapy for Metastatic Breast Cancer;The Breast;2018

5. Identifying Subsets of Metastatic Breast Cancer Patients Likely to Benefit From Treatment With the Epothilone B Analog Ixabepilone;American Journal of Clinical Oncology;2010-12